A screenshot of a COA feels like proof. It is usually only proof that someone could display an image.
Institutions that receive peptide materials — universities, CROs, QA-minded labs — rarely treat a phone crop of a chromatogram or a purity percentage as receiving evidence. They ask whether the document is lot-linked, whether the method is stated, and whether the file can survive an audit trail. Journalism on this desk means explaining that gap without theater.
What a screenshot usually loses
Even when the underlying PDF was real, a screenshot tends to strip the parts that make a COA usable:
- Lot ID continuity — the label, packing list, and COA must share the same lot. A crop often drops the header or footer where that ID lives.
- Method context — column class, detection wavelength, gradient outline, or “in-house method” notes disappear when only the peak is framed.
- Document identity — lab letterhead, report number, page count, and issue date are easy to cut away.
- Integrity signals — digital signatures, controlled PDF properties, or even simple multi-page structure do not travel inside a JPEG.
What remains is aesthetics: a tall peak and a comforting number. That is marketing residue, not a record.
Why institutions reject the pattern
Receiving programs are built to answer a boring question later: what exactly did we take in, under what documentation, on which date? A screenshot fails that question in predictable ways:
- It is not the controlled artifact — the institution’s file system wants the supplier PDF (or equivalent), not a social-media-shaped image.
- It cannot be re-verified cleanly — re-running identity/purity checks needs method and sample context, not a cropped chromatogram.
- It is trivial to detach from the vial in hand — without lot linkage, the image could belong to any lot, any year, any SKU.
- It trains the wrong habit — teams start optimizing for “looks clean” instead of “can be defended.”
What “good enough” documentation looks like instead
For research procurement that wants to stay defensible:
- Lot-linked PDF COA matching the vial label
- Method language sufficient to know what was measured
- Clear separation of identity evidence vs purity/area-% claims
- Storage of the file under the lot ID in the receiving record
- A written rule that screenshots are not accepting documents
Smaller buyers do not need a full GMP binder. They do need the same distinction: image versus record.
How vendors and portals get this wrong
Some catalogs treat “COA available” as a chat upload of a crop. Some buyers accept it because shipping already happened. Both sides then inherit a documentation debt: the material may be fine, but the paperwork cannot prove it later.
Ask for the lot-linked PDF before the argument starts. If a supplier can only produce screenshots, that is already an answer about their quality system — or about how they expect customers to behave.
Refusal list
- Refuse purity claims that exist only inside an image
- Refuse COAs with no lot ID shared with the label
- Refuse “same as last time” screenshots reused across lots
- Refuse identity claims that rest on a UV peak photo alone
Peptide Labs will keep publishing this overlooked layer: not molecule popularity contests, but the document habits that decide whether a lot is usable in a serious workflow.
Educational desk. Not medical advice. Not analytical consulting for a specific lot. Not a substitute for institutional QA policy.